VBI Vaccines (NASDAQ:VBIV) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com started coverage on shares of VBI Vaccines (NASDAQ:VBIV – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Up 1.3 % VBI Vaccines stock opened at $0.59 on Friday. The stock has a market cap of […]
More Stories
Schwab US Large-Cap ETF (NYSEARCA:SCHX) Shares Sold by Kingswood Wealth Advisors LLC
Kingswood Wealth Advisors LLC cut its holdings in shares of Schwab US Large-Cap ETF (NYSEARCA:SCHX – Free Report) by 22.2%...
Blue Trust Inc. Raises Stock Holdings in Boston Scientific Corporation (NYSE:BSX)
Blue Trust Inc. boosted its holdings in shares of Boston Scientific Corporation (NYSE:BSX – Free Report) by 13.0% during the...
Johnson Investment Counsel Inc. Has $936,000 Holdings in Welltower Inc. (NYSE:WELL)
Johnson Investment Counsel Inc. lessened its stake in Welltower Inc. (NYSE:WELL – Free Report) by 15.9% in the 1st quarter,...
Blue Trust Inc. Buys 434 Shares of General Dynamics Corporation (NYSE:GD)
Blue Trust Inc. increased its position in shares of General Dynamics Corporation (NYSE:GD – Free Report) by 26.8% during the...
CWA Asset Management Group LLC Acquires Shares of 1,716 Yum! Brands, Inc. (NYSE:YUM)
CWA Asset Management Group LLC purchased a new position in Yum! Brands, Inc. (NYSE:YUM – Free Report) during the 1st...
Curran Financial Partners LLC Acquires 103 Shares of Meta Platforms, Inc. (NASDAQ:META)
Curran Financial Partners LLC lifted its holdings in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 11.0% in the first...